Furthermore, we analyzed the ALYREF expression in ovarian cancer through a tissue microarray including 134 ovarian cancer patients and found that ALYREF expression was significantly associated with poor survivals (Fig. EV8G,H). Here, ALYREF is linked to ovarian carcinoma.